The response of the lymphoid organs of the mouse to the injection of a Gram-positive (Streptococcus pyogenes) bacterial peptidoglycan (PGL) has been investigated by several complementary techniques. Special cares were brought to: a) the extraction mode and the characterization of the bacterial fraction, b) the sanitary and microbiological status of the mice, and c) the lack of biologically active contaminants, even at a trace level. In these conditions, the local reaction at the site of inoculation was very moderate, transient and not very distinctive. No toxic reactions were observed, even with doses of several milligrams per mouse. Changes in lymphoid organs, as determined by changes in weight, incorporation of radioactive precursors and detailed histological study revealed that PGL did not induce the typical responses of ordinary antigens. Changes in the weight of organs were not significant and there was no dose-response relationship. In the lymph node, the response was confined to the paracortical area; the lymphocyte activation stood at an early stage and became characterized only after booster injection. There was no activation of antibody-producing cells. An important recruitment of active macrophages was observed; this could participate to the adjuvant activity of PGL, whose at least a part of the biological activity is therefore independent of the inflammatory and/or toxic response.

Download full-text PDF

Source

Publication Analysis

Top Keywords

lymphoid organs
12
response lymphoid
8
organs mouse
8
streptococcus pyogenes
8
changes weight
8
response
4
organs
4
mouse peptidoglycan
4
peptidoglycan gram-positive
4
gram-positive bacterium
4

Similar Publications

Pesticides, including fipronil, are used mainly in agriculture; however, in veterinary and animal husbandry, their potential use is to control the pests responsible for vector-borne diseases. Their residues in agriculture products and direct use on farms are responsible for potentially harming livestock and poultry. So, this study was designed to evaluate the toxico-pathological effects of fipronil on the immune system of poultry birds.

View Article and Find Full Text PDF

CD19-CAR T-cell therapy induces deep tissue depletion of B cells.

Ann Rheum Dis

January 2025

Department of Medicine 3-Rheumatology and Immunology, Friedrich-Alexander-Universität (FAU) Erlangen-Nürnberg and Uniklinikum Erlangen, Erlangen, Germany; Deutsches Zentrum Immuntherapie (DZI), Friedrich-Alexander-Universität (FAU) Erlangen-Nürnberg and Uniklinikum Erlangen, Erlangen, Germany, Erlangen, Germany. Electronic address:

Objectives: CD19-targeting chimeric antigen receptor (CAR) T-cell therapy can induce long-term drug-free remission in patients with autoimmune diseases (AIDs). The efficacy of CD19-CAR T-cell therapy is presumably based on deep tissue depletion of B cells; however, such effect has not been proven in humans in vivo.

Methods: Sequential ultrasound-guided inguinal lymph node biopsies were performed at baseline and after CD19-CAR T-cell therapy in patients with AIDs.

View Article and Find Full Text PDF

AIP56, an AB toxin secreted by subsp. , has tropism for myeloid cells.

Front Immunol

January 2025

Fish Immunology and Vaccinology Group, Instituto de Biologia Molecular e Celular (IBMC), Universidade do Porto, Porto, Portugal.

Introduction: The AB-type toxin AIP56 is a key virulence factor of Photobacterium damselae subsp. piscicida (Phdp), inducing apoptosis in fish immune cells. The discovery of AIP56-like and AIP56-related toxins in diverse organisms, including human-associated Vibrio strains, highlights the evolutionary conservation of this toxin family, suggesting that AIP56 and its homologs may share conserved receptors across species.

View Article and Find Full Text PDF

Boosting human immunology: harnessing the potential of immune organoids.

EMBO Mol Med

January 2025

Medical Clinic III for Oncology, Hematology, Immuno-Oncology and Rheumatology, University Hospital Bonn, University of Bonn, Venusberg-Campus 1, 53127, Bonn, Germany.

Studying the human immune system in vivo is challenging and often not possible. Therefore, most human immunology studies have been predominantly confined to peripheral blood analyses, which by themselves have inherent limitations, as many immune reactions take place within tissues. For example, potent antibody responses that contribute to fighting infections and provide protection following vaccination require cellular interactions between B cells and T cells in specialized micro-anatomical structures called germinal centers, which are found in secondary lymphoid organs such as spleen, lymph nodes, and tonsils.

View Article and Find Full Text PDF

Antibody production is central to protection against new pathogens and cancers, as well as to certain forms of autoimmunity. Antibodies often originate in the lymph node (LN), specifically at the extrafollicular border of B cell follicles, where T and B lymphocytes physically interact to drive B cell maturation into antibody-secreting plasmablasts. In vitro models of this process are sorely needed to predict aspects of the human immune response.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!